Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Bolli

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Diabetes, Nutrition & Metabolism|January 25, 2002
Intensive insulin treatment in diabetic childrenJ Ludvigsson, G B Bolli
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitusG B Bolli, G Perriello
Lancet (London, England)|September 12, 2000
Insulin glargineG B Bolli, D R Owens
Endocrinology and Metabolism Clinics of North America|September 29, 1999
Physiology of glucose counterregulation to hypoglycemiaG B Bolli, C G Fanelli
European Journal of Endocrinology|July 25, 1998
Sulphonylureas and pregnancyC G Fanelli, G B Bolli
The New England Journal of Medicine|December 28, 1995
Unawareness of hypoglycemiaG B Bolli, C G Fanelli
The New England Journal of Medicine|March 22, 1984
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitusG B Bolli, J E Gerich
Diabetes Technology & Therapeutics|August 22, 2008
Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical applicationD R Owens, G B Bolli
Diabetes, Obesity & Metabolism|December 31, 2013
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitusG B Bolli, D R Owens
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 4, 2012
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study resultsG B Bolli, A Consoli, A Giaccari
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Diabetes, Nutrition & Metabolism|January 25, 2002
Intensive insulin treatment in diabetic childrenJ Ludvigsson, G B Bolli
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitusG B Bolli, G Perriello
Lancet (London, England)|September 12, 2000
Insulin glargineG B Bolli, D R Owens
Endocrinology and Metabolism Clinics of North America|September 29, 1999
Physiology of glucose counterregulation to hypoglycemiaG B Bolli, C G Fanelli
European Journal of Endocrinology|July 25, 1998
Sulphonylureas and pregnancyC G Fanelli, G B Bolli
The New England Journal of Medicine|December 28, 1995
Unawareness of hypoglycemiaG B Bolli, C G Fanelli
The New England Journal of Medicine|March 22, 1984
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitusG B Bolli, J E Gerich
Diabetes Technology & Therapeutics|August 22, 2008
Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical applicationD R Owens, G B Bolli
Diabetes, Obesity & Metabolism|December 31, 2013
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitusG B Bolli, D R Owens
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 4, 2012
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study resultsG B Bolli, A Consoli, A Giaccari
Pageof 13